Miltefosine in visceral leishmaniasis

Lancet Infect Dis. 2003 Feb;3(2):70. doi: 10.1016/s1473-3099(03)00512-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Animals
  • Antiprotozoal Agents / adverse effects*
  • Fertility / drug effects*
  • Humans
  • Leishmaniasis, Visceral / drug therapy*
  • Male
  • Phosphorylcholine / adverse effects*
  • Phosphorylcholine / analogs & derivatives*

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine